butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of CYP3A4 inducers could minimize sufentanil degrees and efficacy, maybe precipitating withdrawal syndrome in sufferers that have produced Actual physical dependence to sufentanil. D